Should You Buy Amgen Stock At $225?

Amgen stock is down 5% since the start of the year and it has gained around 22% from its March lows. We believe that Amgen could offer an upside in the near term, as the company's revenues in the last three quarters have grown by 9%, primarily aided by its new drug Otezla. This is likely to...